[Experimental chemotherapy in hamsters, using paromomycin against 2 isolates of Leishmania mexicana and Leishmania braziliensis].
D000818:Animals; D000965:Antimony / Q000627:therapeutic use; D006224:Cricetinae; D004353:Drug Evaluation, Preclinical; D007891:Leishmania / Q000187:drug effects*; D007896:Leishmaniasis / Q000188:drug therapy*; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy*; D008297:Male; D008536:Meglumine; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds; D010303:Paromomycin / Q000627:therapeutic use*
D009942:Organometallic Compounds; D010303:Paromomycin; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony
Quimioterapia experimental en hámsteres, por paromomicina, contra dos aislados de Leishmania mexicana y Leishmania braziliensis.